Cibisatamab (CEA-TCB) 是一种 T 细胞双特异性抗体，与癌细胞上的癌胚抗原 (CEA) 和 T 细胞上的CD3结合。Cibisatamab (CEA-TCB) 对细胞表面表达中到高水平 CEA 的癌细胞系触发 T 细胞杀伤。Cibisatamab (CEA-TCB) 可用于结直肠癌研究。
| 生物活性 | Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) oncancercells andCD3on T cells. Cibisatamab (CEA-TCB) triggers T cell killing ofcancercell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectalcancerresearch[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
